|
CN106995858A
|
|
A kind of lncRNA related to liver cancer diagnosis and treatment
|
|
CN106995857A
|
|
Applications of the biomarker ENSG00000267416 in cancer
|
|
CN106893784A
|
|
LncRNA marks for predicting prognosis in hcc
|
|
CN106811548A
|
|
SLC38A4 as adenocarcinoma of colon diagnosis and treatment target
|
|
CN106893778A
|
|
A kind of molecular marker of diagnosis and treatment Dendritic cell
|
|
CN106811532A
|
|
ACTA1 as Dendritic cell diagnosis and treatment mark purposes
|
|
CN106636443A
|
|
Application of DNAH14 gene in tumor diagnosis and treatment
|
|
CN106636444A
|
|
Application of FAM78A gene
|
|
CN106811531A
|
|
Dendritic cell diagnosis and treatment mark
|
|
CN106636408A
|
|
Budd-Chiari syndrome diagnosis tool
|
|
CN105969903A
|
|
Diagnosis and treatment product of hypopharyngeal carcinoma bio-marker
|
|
CN105969901A
|
|
Application of MS4A6A serving as multiple myeloma diagnosis and treatment marker
|
|
CN105969904A
|
|
Multiple myeloma biomarker
|
|
CN105886661A
|
|
Diagnosis and treatment marker for endometrial carcinoma
|
|
CN105886659A
|
|
DSTN gene and expression product thereof as diagnosis and treatment target of endometrial cancer
|
|
CN105886660A
|
|
Application of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) as endometrial cancer diagnosis and treatment marker
|
|
CN105886653A
|
|
Molecular marker of endometrial cancer
|
|
CN105886629A
|
|
Application of molecular marker in diagnosis and treatment of esophageal squamous cell carcinoma
|
|
CN105886625A
|
|
Application of CHKA gene to preparation of esophageal cancer diagnosis and treatment product
|
|
CN105886627A
|
|
Marker for diagnosis and treatment of esophagus cancer
|
